SARNO JOLANDA

Domizi, P., Sarno, J., Jager, A., Merchant, M., Pacheco, K., Yamada-Hunter, S., et al. (2025). IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignancies. NATURE COMMUNICATIONS, 16(1) [10.1038/s41467-025-58868-2]. Detail

Capelletti, M., Montini, O., Ruini, E., Tettamanti, S., Savino, A., Sarno, J. (2025). Unlocking the Heterogeneity in Acute Leukaemia: Dissection of Clonal Architecture and Metabolic Properties for Clinical Interventions. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 26(1) [10.3390/ijms26010045]. Detail

Pan, F., Sarno, J., Jeong, J., Yang, X., Jager, A., Gruber, T., et al. (2024). Genome editing–induced t(4;11) chromosomal translocations model B cell precursor acute lymphoblastic leukemias with KMT2A-AFF1 fusion. THE JOURNAL OF CLINICAL INVESTIGATION, 134(1) [10.1172/JCI171030]. Detail

Colella, P., Sayana, R., Suarez-Nieto, M., Sarno, J., Nyame, K., Xiong, J., et al. (2024). CNS-wide repopulation by hematopoietic-derived microglia-like cells corrects progranulin deficiency in mice. NATURE COMMUNICATIONS, 15(1) [10.1038/s41467-024-49908-4]. Detail

Sarno, J., Domizi, P., Liu, Y., Merchant, M., Pedersen, C., Jedoui, D., et al. (2023). Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia. NATURE COMMUNICATIONS, 14(1) [10.1038/s41467-023-38456-y]. Detail